Neurolmed

NeurolMed is a South Korean biopharmaceutical company focused on the development of drugs derived from biomolecules and natural products for the treatment of acute and chronic degenerative cerebral disorders. Its therapeutic pipeline targets stroke, Parkinson's disease, Alzheimer's disease, and related central nervous system conditions. The company integrates expertise in biology and chemistry to perform all stages of early drug development in-house, from target identification through preclinical research. NeurolMed's stated goal is to develop fundamental and definitive cures for degenerative brain diseases that currently have limited treatment options.